Explore groundbreaking studies in medicinal chemistry, drug design methodologies, and therapeutic discovery
Exploring Rpn11/POH1/PSMD14 as a novel therapeutic target in multiple myeloma treatment, overcoming resistance to current proteasome inhibitors.